4.3 Article

Expression of Vitamin D Receptor and Metabolizing Enzymes in Multiple Sclerosis-Affected Brain Tissue

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

Merja Soilu-Hanninen et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)

Article Clinical Neurology

Vitamin D in the healthy and inflamed central nervous system: access and function

Joost Smolders et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)

Article Multidisciplinary Sciences

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer et al.

NATURE (2011)

Article Medicine, General & Internal

Vitamin D and Risk of Cognitive Decline in Elderly Persons

David J. Llewellyn et al.

ARCHIVES OF INTERNAL MEDICINE (2010)

Article

Serum Vitamin D and the Risk of Parkinson Disease

Paul Knekt et al.

ARCHIVES OF NEUROLOGY (2010)

Review Clinical Neurology

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

Charles Pierrot-Deseilligny et al.

BRAIN (2010)

Article Clinical Neurology

25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis

Trygve Holmoy et al.

MULTIPLE SCLEROSIS (2009)

Article Psychiatry

Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases

D.A. Fernandes de Abreu et al.

PSYCHONEUROENDOCRINOLOGY (2009)

Article Clinical Neurology

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

J. Smolders et al.

MULTIPLE SCLEROSIS JOURNAL (2008)

Article Clinical Neurology

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions

Nathalie Koning et al.

ANNALS OF NEUROLOGY (2007)

Article Clinical Neurology

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

I. A. F. van der Mei et al.

JOURNAL OF NEUROLOGY (2007)

Article Clinical Neurology

The immunopathology of multiple sclerosis:: An overview

Hans Lassmann et al.

BRAIN PATHOLOGY (2007)

Article Medicine, General & Internal

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

Kassandra L. Munger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Biochemistry & Molecular Biology

Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite

Eva Gottfried et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Biochemistry & Molecular Biology

Vitamin D physiology

P. Lips

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Distribution of the Vitamin D receptor and 1 alpha-hydroxylase in human brain

DW Eyles et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2005)

Review Biochemistry & Molecular Biology

Enzymes involved in the activation and inactivation of vitamin D

DE Prosser et al.

TRENDS IN BIOCHEMICAL SCIENCES (2004)

Article Biochemical Research Methods

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

D Dumont et al.

PROTEOMICS (2004)

Article Neurosciences

Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line

CL d'Hellencourt et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2003)

Article Multidisciplinary Sciences

Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3

A Nykjaer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Endocrinology & Metabolism

Extrarenal expression of 25-hydroxyvitamin D3-1α-hydroxylase

D Zehnder et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)

Review Clinical Neurology

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS

P van der Valk et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)